_2024-ceo-chat-conley-chee-ceo-of-syros-pharmaceuticals-preview-1.jpg "2024 CEO Chat: Conley Chee, CEO of Syros Pharmaceuticals from oscine therapeutics Video Screenshot Preview 1")
Gallery_2024-ceo-chat-conley-chee-ceo-of-syros-pharmaceuticals-preview-3.jpg "2024 CEO Chat: Conley Chee, CEO of Syros Pharmaceuticals from oscine therapeutics Video Screenshot Preview 3")
Gallery_2024-ceo-chat-conley-chee-ceo-of-syros-pharmaceuticals-preview-hqdefault.jpg "2024 CEO Chat: Conley Chee, CEO of Syros Pharmaceuticals from oscine therapeutics Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 6 minutes 5 seconds
👁 View: 184 times
Play Audio:👁 View: 184 times
Description:
Flagship Pioneering
Flagship Pioneering
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_crispr-therapeutics-ceo-science-in-gene-editing-is-moving-at-break-neck-speed.webp "CNBC Television")
⏲ 3 minutes 39 seconds 👁 9.7K
_cell-therapies-amp-the-future-of-biotech-124.webp "SALT")
_the-ceo-of-this-innovative-biopharma-is-bringing-light-to-cancer-research.webp "Paul Peter Tak, MD, PhD, FMedSci, President & CEO of Candel Therapeutics, was recently a guest on Benzinga's All-Acess.<br/><br/>Candel is a clinical-stage biopharmaceutical company focused on developing immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The company has two main platforms that are currently undergoing clinical trials. <br/><br/>Candel also has its enLIGHTEN™ program, a systematic, iterative discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.")
_episode-3-how-to-start-your-own-biotech-company-part-1-therapeutics.webp "NCI Scientific Events and Resources")
_cathie-wood-9234mark-my-words-everyone-who-own-these-3-stocks-will-become-millionaire-by-end-of-20249234.webp "Millionaires Investment Secrets")
⏲ 14 minutes 56 seconds 👁 250.1K
_reaction-cathie-wood-on-crispr-amp-genomic-stocks.webp "The Market Mindset")
_crispr39s-next-advance-is-bigger-than-you-think-124-jennifer-doudna-124-ted.webp "TED")
⏲ 7 minutes 37 seconds 👁 335.4K
_crsp-stock-on-wild-ride-after-fda39s-historic-approval-these-gene-editing-treatments-could-be-next.webp "Alexis Garcia")
⏲ 15 minutes 51 seconds 👁 55K
_crispr-therapeutics-ceo-science-in-gene-editing-is-moving-at-break-neck-speed.jpg)
_cell-therapies-amp-the-future-of-biotech-124.jpg)
_the-ceo-of-this-innovative-biopharma-is-bringing-light-to-cancer-research.jpg)
_episode-3-how-to-start-your-own-biotech-company-part-1-therapeutics.jpg)
_cathie-wood-9234mark-my-words-everyone-who-own-these-3-stocks-will-become-millionaire-by-end-of-20249234.jpg)
_reaction-cathie-wood-on-crispr-amp-genomic-stocks.jpg)
_crispr39s-next-advance-is-bigger-than-you-think-124-jennifer-doudna-124-ted.jpg)
_crsp-stock-on-wild-ride-after-fda39s-historic-approval-these-gene-editing-treatments-could-be-next.jpg)
![[+]](/images/menu.gif){kind=small}